Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 3.73 -10.53% -0.44
VRPX closed down 10.53 percent on Monday, March 18, 2024, on 18 percent of normal volume.
Earnings due: Mar 28
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish -10.53%
50 DMA Support Bullish -10.53%
Wide Bands Range Expansion -10.53%
50 DMA Support Bullish -3.62%

   Recent Intraday Alerts

Alert Time
20 DMA Support about 11 hours ago
Down 1 ATR about 11 hours ago
Possible NR7 about 12 hours ago
Possible Inside Day about 12 hours ago
60 Minute Opening Range Breakdown about 15 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Virpax Pharmaceuticals, Inc. Description

Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pain Euphoriants Opioids Influenza Pain Management Drug Delivery Analgesics Morphinans Post Traumatic Stress Disorder Drug Delivery Systems Heroin Bupivacaine Morphine Nasal Administration

Is VRPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.774
52 Week Low 2.402
Average Volume 23,903
200-Day Moving Average 6.58
50-Day Moving Average 3.45
20-Day Moving Average 3.66
10-Day Moving Average 4.13
Average True Range 0.56
RSI (14) 51.22
ADX 39.66
+DI 29.12
-DI 16.58
Chandelier Exit (Long, 3 ATRs) 3.81
Chandelier Exit (Short, 3 ATRs) 4.37
Upper Bollinger Bands 4.83
Lower Bollinger Band 2.50
Percent B (%b) 0.53
BandWidth 63.39
MACD Line 0.16
MACD Signal Line 0.16
MACD Histogram -0.0018
Fundamentals Value
Market Cap 43.69 Million
Num Shares 11.7 Million
EPS -1.17
Price-to-Earnings (P/E) Ratio -3.19
Price-to-Sales 0.00
Price-to-Book 0.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.37
Resistance 3 (R3) 4.38 4.17 4.26
Resistance 2 (R2) 4.17 4.00 4.16 4.23
Resistance 1 (R1) 3.95 3.90 3.85 3.94 4.19
Pivot Point 3.74 3.74 3.69 3.74 3.74
Support 1 (S1) 3.52 3.58 3.42 3.52 3.27
Support 2 (S2) 3.31 3.48 3.31 3.23
Support 3 (S3) 3.10 3.31 3.20
Support 4 (S4) 3.09